NAFDAC Registration Guide: Step-by-Step Process

Registration Categories: Which One Applies to You?

NAFDAC doesn't use a one-size-fits-all approach. Your product falls into one of several categories, each with different requirements, timelines, and costs.

Category A: New Chemical Entities (NCEs)

Brand new active pharmaceutical ingredients never before registered in Nigeria. This is the most rigorous pathway requiring full clinical data, stability studies, and often local clinical trials. Timeline: 12-24 months. Cost: $5,000-$15,000+.

Category B: Generic Drugs

Products containing APIs already registered in Nigeria by other companies. This is the most common pathway for Indian and Chinese generic manufacturers. Requires bioequivalence studies unless a waiver applies. Timeline: 9-15 months. Cost: $3,000-$8,000.

Category C: Existing Registered Products (Line Extensions)

New strengths, dosage forms, or formulations of products already registered by your company. Faster pathway since safety data already exists. Timeline: 6-9 months. Cost: $1,500-$3,000.

Category D: Over-the-Counter (OTC) & Herbal Medicines

Simplified documentation for non-prescription products and traditional medicines. Still requires GMP evidence and quality data but less clinical information. Timeline: 6-12 months. Cost: $1,000-$3,000.

Category E: Vaccines & Biologics

The most stringent pathway. Requires WHO Prequalification or approval by a Stringent Regulatory Authority (SRA) like US FDA or EMA. Additional lot release testing required for every batch. Timeline: 12-24 months. Cost: $10,000-$25,000+.

Prerequisites: What You Need Before Starting

Before you submit a single page to NAFDAC, you need to have these items locked down. Missing any of them will result in immediate rejection or months of back-and-forth correspondence.

• Appoint a Local Technical Representative (LTR): Foreign manufacturers cannot hold a NAFDAC registration. You need a Nigerian company with a current NAFDAC importer license to be your legal representative. Choose wisely—you're married to this LTR for the registration's duration.
• Execute a Power of Attorney (PoA): A notarized, legalized document authorizing your LTR to act on your behalf. Must be apostilled or authenticated by the Nigerian embassy in your country.
• Obtain a Certificate of Pharmaceutical Product (CPP): Issued by the regulatory authority in your manufacturing country (e.g., CDSCO in India, FDA in USA, HPRA in Ireland). Must be in WHO format and less than 2 years old.
• Prepare Your GMP Evidence: A current GMP certificate from your local regulator or evidence of WHO PQ/SRA approval.
• Establish a Nigerian Bank Account (Optional but Recommended): Your LTR will need to pay NAFDAC fees in Naira. Having a local account streamlines this.

Step-by-Step Registration Process

Here's the actual journey your dossier takes through NAFDAC's system. I've broken this down into actionable steps based on successful registrations I've managed.

Step 1: Pre-Submission Meeting (Optional but Highly Recommended)

Before you invest in full dossier preparation, request a pre-submission meeting with NAFDAC's Directorate of Registration and Regulatory Affairs (DRRA). Present your product, ask specific questions about requirements, and get informal feedback. This meeting costs nothing (except your time) and can save you months of rejection cycles. Schedule through your LTR.

Step 2: Dossier Compilation & CTD Formatting

Compile your dossier in strict CTD format (Modules 1-5). NAFDAC provides detailed guidelines on their portal. Common mistakes at this stage include missing Module 1 administrative documents, incomplete stability data, and poor-quality PDFs. Budget for a regulatory consultant if this is your first Nigerian registration.

Step 3: Online Submission via NAFDAC's e-Registration Portal

NAFDAC has digitized its submission process. Your LTR creates an account on the NAFDAC e-Reg portal, uploads the dossier (PDFs under 25MB each), and pays the application fee online. You'll receive an acknowledgement receipt with a reference number immediately.

Step 4: Administrative Screening (2-4 weeks)

NAFDAC checks for completeness. Do you have all required documents? Are they properly notarized and legalized? Is the CPP valid? If anything is missing, your application is returned with a deficiency letter. Each correction cycle adds 2-4 weeks.

Step 5: Scientific Evaluation (4-12 months)

This is the longest phase. Your dossier is assigned to evaluators in NAFDAC's various directorates: Pharmaceutical Evaluation, Clinical Trials, Microbiology, Pharmacology/Toxicology, etc. They review:

• Quality data (Module 3): Manufacturing process, specifications, stability, excipients
• Safety data (Module 4): Preclinical pharmacology/toxicology (for NCEs)
• Efficacy data (Module 5): Clinical trial results or bioequivalence study (for generics)

Evaluators issue queries (requests for additional information). You typically have 90 days to respond. Each query cycle adds 2-4 months. Well-prepared dossiers might have 1-2 query cycles. Poor dossiers can have 4-5 cycles or be rejected outright.

Step 6: GMP Inspection (If Required)

If your manufacturing site hasn't been inspected by NAFDAC before (or within the last 2-3 years), they will schedule an inspection. This can happen concurrently with scientific evaluation or after. See the detailed inspection section below.

Step 7: Registration Committee Approval (2-4 weeks)

Once evaluators are satisfied, your file goes to NAFDAC's Drug Registration Committee. This committee meets monthly. They issue the final approval or, rarely, reject the application. Approved products receive a Certificate of Registration (CoR) and a NAFDAC Registration Number (e.g., A4-12345).

Step 8: Publication in NAFDAC Bulletin (4-8 weeks)

Approved products are published in the official NAFDAC Bulletin—a public record of all registered products. Your registration is not officially active until publication occurs.

Step 9: Post-Registration Formalities

Submit product artwork (labels, cartons, leaflets) showing the NAFDAC number for approval. Pay the registration certificate fee. Receive the final, stamped Certificate of Registration.

Dossier Requirements: The Complete CTD Breakdown

NAFDAC follows the ICH Common Technical Document (CTD) format. Here's exactly what goes into each module.

Module 1: Administrative Information (Country-Specific)

• Application letter on manufacturer letterhead
• Cover letter from LTR on Nigerian company letterhead
• Power of Attorney (notarized & legalized)
• Certificate of Pharmaceutical Product (WHO format, notarized)
• GMP Certificate from manufacturing country (notarized)
• Free Sale Certificate or Certificate of Export (notarized)
• Manufacturing license from country of origin (notarized)
• Product samples information (batch numbers, quantities)
• Labeling and package insert (mock-ups for approval)
• Patent declaration (stating product doesn't infringe Nigerian patents)

Module 2: Summaries

• Quality Overall Summary (QOS)
• Nonclinical Overview & Summary (for NCEs)
• Clinical Overview & Summary (or Bioequivalence summary for generics)

Module 3: Quality (Pharmaceutical Documentation)

• Drug substance (API): Manufacturing process, characterization, impurity profile, specifications
• Drug product (finished product): Formulation, manufacturing process, specifications, excipients
• Stability data: Zone IV (hot & humid) conditions. Minimum 6 months accelerated, 12 months long-term at submission. 24-36 months long-term for final registration.
• Container closure system: Packaging specifications, compatibility data

Module 4: Nonclinical Reports (NCEs Only)

• Pharmacology studies
• Pharmacokinetics/ADME
• Toxicology studies (single-dose, repeat-dose, genotoxicity, reproductive, carcinogenicity)

Module 5: Clinical Reports

• For NCEs: Full clinical trial reports (Phase 1-3)
• For Generics: Bioequivalence study report comparing your product to the reference product (unless a BCS-based biowaiver applies)
• For OTC/Well-Established Use: Literature review and safety/efficacy references

Facility Inspection: The GMP Audit

This is the hurdle that breaks many registrations. NAFDAC will inspect your manufacturing facility to verify that your written GMP documentation matches reality.

When is an inspection required?

• First-time registration from your facility in Nigeria
• No inspection in the last 2-3 years
• Serious GMP deficiencies identified in previous inspection
• Significant changes to manufacturing site or process
• NAFDAC's discretion (they inspect many facilities proactively)

Inspection process:

1. NAFDAC notifies your LTR of the inspection date (typically 4-8 weeks notice)
2. You pay the inspection fee ($8,000-$15,000 plus travel expenses for 2-3 inspectors)
3. NAFDAC inspectors visit your facility for 3-5 days
4. They review your quality management system, production areas, quality control lab, warehousing, water system, HVAC, and documentation
5. They issue an inspection report with findings (critical, major, minor deficiencies)
6. You respond with a corrective action and preventive action (CAPA) plan
7. If satisfactory, NAFDAC issues a GMP clearance letter

Pro tip: NAFDAC accepts WHO PQ and SRA approvals as evidence of GMP compliance, potentially waiving the need for a physical inspection. If your facility has recent US FDA or EMA approval, highlight this prominently in your dossier.

Costs & Timelines: Realistic Expectations

Let's talk money and time. NAFDAC's official fees are published, but the total cost depends heavily on your product category and whether a physical inspection is required.

Official NAFDAC Fees (Approximate, subject to change)

• Application/screening fee: ₦50,000-100,000 ($100-200)
• Evaluation fee (Category A): ₦500,000-1,000,000 ($1,000-2,000)
• Evaluation fee (Category B): ₦300,000-500,000 ($600-1,000)
• Registration certificate fee: ₦200,000-500,000 ($400-1,000)
• Annual retention fee (after registration): ₦100,000-200,000 ($200-400 per product per year)

Third-Party Costs (Your Real Expenses)

• Regulatory consultant fees: $5,000-$15,000 per product (or monthly retainer)
• Document legalization/apostille: $500-$2,000 depending on country
• GMP inspection (if required): $10,000-$20,000 including inspector travel, accommodation, per diem
• Bioequivalence study (for generics): $50,000-$150,000 if a new study is needed
• Stability studies: $10,000-$30,000 for 12-24 months of Zone IV testing

Total Estimated Cost Per Product

• Category B (Generic, no inspection, existing BE data): $8,000-$15,000
• Category B (Generic, with inspection, existing BE): $18,000-$35,000
• Category A (NCE, with inspection, full clinical data): $30,000-$80,000+

Timeline Realities

• Best case (fast-track, SRA-approved product): 4-6 months
• Average case (generic, well-prepared dossier): 9-12 months
• Worst case (NCE, poor dossier, multiple queries, inspection delays): 18-24 months

Common Reasons for Rejection & How to Avoid Them

After reviewing dozens of NAFDAC rejections and deficiency letters, here are the most common failure modes.

• Invalid or Expired CPP: Your Certificate of Pharmaceutical Product must be in WHO format, issued within the last 2 years, and properly legalized. A CPP more than 24 months old is an automatic rejection.
• Missing Notarization/Apostille: Every document from outside Nigeria must be notarized and apostilled (or legalized at the Nigerian embassy). NAFDAC will not accept plain photocopies.
• Inadequate Stability Data: Zone IV data (30°C/75% RH or 40°C/75% RH accelerated) is required. Submitting Zone II data (Mediterranean climate) guarantees rejection.
• Bioequivalence Issues: For generics, your BE study must use the correct reference product (the innovator product registered in Nigeria, not a different market). Study reports must be complete and signed.
• GMP Certificate Problems: Your GMP certificate must be current (usually within 3 years), from a credible authority, and cover the specific dosage form you're registering.
• Product Sampled Failed Testing: NAFDAC will request samples for laboratory testing. If your product fails their quality tests (assay, impurities, dissolution), registration is rejected.
• Incorrect Labeling: Your proposed labeling must include the NAFDAC number (once assigned), batch number, manufacturing date, expiry date, storage conditions, and "For distribution in Nigeria only."
• Power of Attorney Issues: PoA must specifically name your LTR company, be valid for at least 5 years, and be properly notarized/legalized.

Post-Registration Obligations

Getting the registration certificate is not the finish line. NAFDAC has ongoing requirements to keep your registration active.

• Annual Retention Fees: Payable each year by the anniversary of registration. Late payment incurs penalties. Non-payment for 2+ years results in deregistration.
• Variations & Changes: Any change to manufacturing site, formulation, specifications, or packaging requires NAFDAC notification and often a variation application. Minor changes (e.g., supplier of excipient) may just need notification. Major changes (e.g., new manufacturing site) require a full variation submission with fees.
• Renewal: Initial registration is typically valid for 3-5 years (varies by product category). Renewal requires submission of updated dossiers, current GMP certificates, and evidence of continued compliance.
• Pharmacovigilance: You must have a PV system to collect and report adverse events to NAFDAC. Periodic Safety Update Reports (PSURs) are required annually or biennially.
• Post-Market Surveillance: NAFDAC may conduct market surveillance, sampling your product from Nigerian pharmacies for testing. Failures can lead to product recalls or registration suspension.
• Batch Certification (for vaccines/biologics): Some products require NAFDAC lot release testing for each batch before distribution in Nigeria.

Renewal Procedures: Keeping Your Registration Active

NAFDAC registrations are not perpetual. You must renew before expiration to avoid interruption in your ability to import.

When to renew: Start the renewal process 6 months before expiration. NAFDAC processing takes 3-6 months.

Renewal requirements:

• Updated CTD dossier with any changes since original registration
• Current GMP certificate (less than 3 years old)
• Updated CPP (less than 2 years old)
• Evidence of annual fee payment for all years of registration
• Pharmacovigilance summary including PSURs
• Stability update (confirming product remains stable through shelf life)
• Renewal fee (typically 50-100% of original registration fee)

Consequences of late renewal:

• Grace period of 30-90 days (with penalty fees)
• After grace period: Registration lapses completely
• Lapsed registration requires full de novo registration (starting from scratch)
• Products already in the Nigerian market must be recalled

Fast-Track & Special Pathways

Not all registrations go through the full 12-18 month cycle. NAFDAC offers accelerated pathways for certain products.

WHO Prequalification (PQ) Fast-Track: Products with WHO PQ receive priority evaluation (4-6 months instead of 9-12 months). Reduced documentation requirements. This is the most valuable fast-track for generic manufacturers.

Stringent Regulatory Authority (SRA) Recognition: Products approved by US FDA, EMA, Health Canada, TGA (Australia), or PMDA (Japan) qualify for accelerated review. Submit your SRA approval letter and reduced dossier.

National Emergency/Public Health Priority: For products addressing public health emergencies (e.g., pandemics, outbreaks), NAFDAC has an emergency use authorization pathway. Timelines: 2-8 weeks.

ECOWAS Harmonization: If your product is registered in another ECOWAS country (Ghana, Côte d'Ivoire, Senegal) under the ECOWAS harmonization procedure, NAFDAC may accept that assessment. Not fully implemented but promising.

Conclusion: Your NAFDAC Registration Checklist

Navigating NAFDAC registration is not for amateurs. The agency has legitimate quality standards, and they enforce them. But with proper preparation, a competent local partner, and realistic timelines, registration is absolutely achievable.

Here's your pre-submission checklist:

• ✓ Local Technical Representative appointed (reputable, experienced company)
• ✓ Power of Attorney executed, notarized, apostilled
• ✓ CPP obtained from home regulator, in WHO format, less than 2 years old
• ✓ GMP certificate current, covering your dosage form
• ✓ CTD dossier compiled (Modules 1-5) with Zone IV stability data
• ✓ Bioequivalence study (if generic) or clinical data (if NCE) ready
• ✓ All foreign documents notarized and apostilled/legalized
• ✓ Product samples available for NAFDAC testing (when requested)
• ✓ Budget allocated for registration fees, consultant, and potential inspection
• ✓ Timeline: 12 months minimum from submission to approval

The Nigerian pharmaceutical market is massive and growing. It's worth the regulatory investment. But go in with eyes open: NAFDAC will test your patience, your documentation, and your bank account. The exporters who succeed are the ones who treat registration as a strategic project, not a box-ticking exercise.

Need help? Consider hiring a Nigerian regulatory affairs consultant who has successfully registered products with NAFDAC before. Their knowledge of the agency's unwritten expectations and relationships with evaluators can shave months off your timeline. In the world of African pharma regulation, experience isn't just valuable—it's everything.